|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) University of Alabama at Birmingham University of California, San Diego University of Maryland University of Pittsburgh University of Texas University of Utah Beaumont Hospital Loyola University New England Research Institutes |
Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
ClinicalTrials.gov Identifier: | NCT00064662 |
The primary aim of this clinical trial is to compare the treatment success for two surgical procedures that are frequently used and have similar cure rates, yet have not been compared directly to each other in a large, rigorously conducted randomized trial. The secondary aims of the trial are to compare other outcomes for the two surgical procedures, including quality of life, sexual function, satisfaction with treatment outcomes, complications, and need for other treatment(s)after surgery. Follow-up will be a minimum of two years and up to four years.
Condition | Intervention | Phase |
Urinary Incontinence |
Procedure: Burch Modified Tanagho Procedure: Autologous Fascia Sling |
Phase II Phase III |
MedlinePlus related topics: | Pelvic Support Problems Stress Urinary Incontinence |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Randomized Clinical Trial of the Burch Modified Tanagho and Autologous Fascia Sling Procedures for Women With Predominantly Stress Urinary Incontinence |
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
United States, Alabama | |||||
University of Alabama | |||||
Birmingham, Alabama, United States, 35249-7333 | |||||
United States, California | |||||
University of California | |||||
San Diego, California, United States, 92037 | |||||
United States, Illinois | |||||
Loyola University Medical Center | |||||
Maywood, Illinois, United States, 60153 | |||||
United States, Maryland | |||||
University of Maryland | |||||
Baltimore, Maryland, United States, 21201 | |||||
United States, Michigan | |||||
Beaumont Hospital | |||||
Royal Oak, Michigan, United States, 48073 | |||||
United States, Pennsylvania | |||||
University of Pittsburgh | |||||
Pittsburgh, Pennsylvania, United States, 15213 | |||||
United States, Texas | |||||
University of Texas, Southwestern | |||||
Dallas, Texas, United States, 75390-9110 | |||||
University of Texas Health Sciences Center | |||||
San Antonio, Texas, United States, 78229-3900 | |||||
United States, Utah | |||||
University of Utah | |||||
Salt Lake City, Utah, United States, 84132 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
University of Alabama at Birmingham |
University of California, San Diego |
University of Maryland |
University of Pittsburgh |
University of Texas |
University of Utah |
Beaumont Hospital |
Loyola University |
New England Research Institutes |
Study Chair: | William D. Steers, M.D. | University of Virginia |
www.uitn.net 
  |
Responsible Party: | NIDDK ( Debuene Chang, MD ) |
Study ID Numbers: | UITN-RCT |
First Received: | July 10, 2003 |
Last Updated: | December 21, 2007 |
ClinicalTrials.gov Identifier: | NCT00064662 |
Health Authority: | United States: Federal Government |
|
|
|
|